NTHRYS
PDF

Somatic Variant Analysis and Tumor-Normal Pipelines Workshop

Master somatic mutation profiling through tumor-normal comparison pipelines, variant filtering, annotation, interpretation, and reporting for cancer genomics.

Home > Workshops > Somatic Mutation Profiling and Tumor-Normal Comparison Pipeline Workshop

Somatic Mutation Profiling and Tumor-Normal Comparison Pipeline Workshop

Somatic Variant Analysis and Tumor-Normal Pipelines Workshop
Workshop IndexDuration: 2 DAYS
Use the index to navigate the workshop sections and open quick reference modals for scope, audience, outcomes, delivery, policies, and FAQs.
Quick Summary
Cancer GenomicsPipeline WorkshopApplied Training
Workshop Scope, Audience, and Analytical Context
  • Learn the end-to-end logic of tumor-normal comparison pipelines for detecting somatic SNVs, indels, and clinically relevant variant patterns in matched sequencing data.
  • Somatic VariantsTumor-Normal
  • Review experimental assumptions affecting somatic calling quality, including sample purity, contamination, sequencing depth, duplicate burden, and panel versus exome design.
  • Sequencing DesignQuality Control
  • Interpret how alignment, preprocessing, local realignment surrogates, base recalibration, and artifact suppression influence confident somatic variant detection.
  • PreprocessingAlignment Logic
  • Compare caller behavior across low allele fraction mutations, subclonal events, FFPE artifacts, and challenging genomic regions relevant to cancer samples.
  • Low VAFArtifact Review
  • Position the workflow for researchers, translational scientists, molecular diagnosticians, and bioinformatics teams handling somatic mutation interpretation pipelines.
  • Translational TeamsClinical Research
  • Connect raw sequencing output to structured reporting through filtering, annotation, prioritization, evidence review, and reproducible result packaging.
  • AnnotationReporting
Overview
Variant CallingHands-On DesignResearch Grade
Conceptual Framework and Learning Outcomes
  • Map the major stages of a somatic mutation profiling workflow from FASTQ and BAM quality assessment through paired analysis, filtering, annotation, and curation.
  • Workflow MappingPaired Analysis
  • Distinguish somatic from germline events using matched normal data, population resources, panel of normals, and evidence-aware filtering logic.
  • Germline ExclusionPanel Of Normals
  • Evaluate caller outputs using depth, strand bias, mapping quality, orientation bias, contamination estimates, and site-level confidence metrics.
  • Call MetricsConfidence Review
  • Build strategies to prioritize variants by oncogenic relevance, functional impact, pathway context, hotspot evidence, and knowledgebase-supported interpretation.
  • Oncology RelevanceFunctional Impact
  • Understand how reproducibility, workflow documentation, and parameter transparency support reliable somatic profiling in research and translational settings.
  • ReproducibilityParameter Tracking
  • Gain confidence in generating interpretation-ready outputs suitable for downstream molecular review, tumor board preparation, or exploratory biomarker studies.
  • Interpretation ReadyBiomarker Studies
Agenda
Pipeline PracticeCase BasedInstructor Led
Agenda Flow and Hands-On Components
  • Set up a reference analytical environment and inspect input tumor-normal datasets for read quality, coverage sufficiency, contamination signals, and sample identity checks.
  • Environment SetupQC Review
  • Walk through alignment-aware preprocessing decisions, duplicate marking, recalibration concepts, and preparation steps needed before somatic calling.
  • Pre-CallingData Readiness
  • Execute tumor-normal comparison logic and examine raw somatic callsets with emphasis on allele fraction, depth support, and artifact-sensitive regions.
  • Callset ReviewAllele Fraction
  • Apply filtering workflows using quality flags, population databases, panel of normals, and caller-specific evidence to refine a high-confidence somatic set.
  • Filtering LogicHigh Confidence
  • Annotate prioritized variants with transcript effect, cancer relevance, hotspot status, pathway associations, and interpretation-supporting database evidence.
  • Variant AnnotationKnowledgebases
  • Review curated outputs through mini case studies involving subclonal mutations, low purity tumors, and discordant calls between tools or filters.
  • Case StudiesDiscordant Calls
  • Package final results into reproducible summary tables, interpretation notes, and workflow documentation suitable for downstream reporting or review.
  • Result PackagingDocumentation
Deliverables
OutputsReference MaterialPractical Support
Deliverables, Support Notes, and Frequently Asked Questions
  • Receive structured workshop notes covering tumor-normal comparison design, somatic calling checkpoints, filtering logic, annotation flow, and interpretation strategy.
  • Workshop NotesPipeline Guide
  • Get curated practice files, example callsets, and output templates that support repetition of the analytical steps after the session.
  • Practice FilesTemplates
  • Access annotated reference checklists for variant review, artifact triage, and result documentation in cancer sequencing studies.
  • Review ChecklistsArtifact Triage
  • FAQ: Is prior coding experience mandatory? No. The workshop explains each pipeline stage conceptually and operationally for guided execution and interpretation.
  • Beginner FriendlyGuided Execution
  • FAQ: Does the workshop focus on one tool only? No. It emphasizes transferable tumor-normal analysis principles, comparative caller behavior, and best-practice reasoning.
  • Tool AgnosticBest Practices
  • FAQ: What can participants do afterward? They can assess paired samples, refine somatic callsets, annotate variants, and assemble interpretation-ready summaries.
  • Post Workshop SkillsInterpretation Summaries

Overview

  • Learn the end-to-end logic of tumor-normal comparison pipelines for detecting somatic SNVs, indels, and clinically relevant variant patterns in matched sequencing data.
  • Review experimental assumptions affecting somatic calling quality, including sample purity, contamination, sequencing depth, duplicate burden, and panel versus exome design.
  • Interpret how alignment, preprocessing, local realignment surrogates, base recalibration, and artifact suppression influence confident somatic variant detection.
  • Compare caller behavior across low allele fraction mutations, subclonal events, FFPE artifacts, and challenging genomic regions relevant to cancer samples.
  • Connect raw sequencing output to structured reporting through filtering, annotation, prioritization, evidence review, and reproducible result packaging.

Who should attend

  • Molecular geneticists, cancer genomics researchers, translational scientists, bioinformatics analysts, pathologists in research environments, and sequencing teams working with paired tumor-normal data.

Learning outcomes

  • Map complete somatic profiling workflows from input assessment through curation.
  • Separate somatic and germline signals using matched normal evidence and filtering logic.
  • Evaluate caller outputs and quality metrics for confident mutation review.
  • Prioritize variants by oncogenic relevance, function, and evidence sources.
  • Generate reproducible interpretation-ready summaries for downstream review.

Agenda

  • Reference environment setup, sample QC, preprocessing review, tumor-normal calling, filtering, annotation, case-based interpretation, and result packaging.

Hands-on / Demonstrations

  • Inspect QC metrics, review callsets, apply filters, annotate variants, interpret low VAF events, and organize documentation-ready outputs.

Deliverables

  • Workshop notes, practice datasets, example callsets, output templates, and reference checklists for somatic review workflows.

FAQ

  • Prior coding exposure is helpful but not mandatory.
  • The workshop focuses on transferable analysis logic rather than one tool only.
  • Participants finish with practical tumor-normal comparison and somatic interpretation workflow understanding.